Medical device lifecycles are compressed, overlapping, and increasingly competitive. From concept to clearance takes two to seven years, but the real challenge is what comes after — post-market surveillance obligations, competitive obsolescence threats, technology refresh decisions, and installed base migration. Most organizations manage these phases with disconnected tools, losing institutional intelligence every time a product transitions from one lifecycle stage to the next.
Behavior Labs delivers a unified decision intelligence platform across the full 12-stage device lifecycle — from concept and need identification through design, regulatory clearance, market launch, post-market surveillance, and end-of-service transition. One knowledge graph, compounding across every product in your portfolio.
Device lifecycle management is not a single decision — it is a continuous sequence of interdependent decisions spanning years, crossing functional boundaries, and requiring intelligence that compounds rather than resets at each stage transition.
Navigate the device regulatory landscape across 510(k), De Novo, PMA, and EU MDR pathways. Predicate analysis, submission strategy, and FDA review intelligence that adapts to your specific device classification and competitive context.
Monitor MAUDE databases, MDR trends, complaint patterns, and field performance anomalies. Detect emerging signals before they reach regulatory thresholds — the difference between a proactive field action and an FDA-mandated recall.
Track competitor development programs, assess technology disruption risk, and model installed base migration scenarios. Time your product refresh cycle to defend market position rather than react to competitive launches.
Track lifecycle position across every device in your portfolio. Identify investment timing, transition triggers, evidence maturity gaps, and decision debt — the accumulation of deferred decisions that compound risk the longer they go unaddressed.
The medical device landscape demands continuous lifecycle intelligence across an increasingly compressed development-to-obsolescence cycle.
See how lifecycle decision intelligence delivers continuous, compounding intelligence across your full device portfolio.
